On the accuracy of a one-compartment approach for determination of drug terminal half-life

被引:3
|
作者
Berezhkovskiy, Leonid M. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
terminal half-life; steady state volume of distribution; terminal volume of distribution; clearance; mean residence time; blood flow; blood-plasma ratio; hepatic clearance; physiological model; pharmacikinetics; STEADY-STATE; PHYSIOLOGICAL-PARAMETERS; PHARMACOKINETICS; VOLUME; PREDICTION; CLEARANCE; BODY;
D O I
10.1002/jps.23565
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The drug terminal half-life (t1/2) is commonly predicted by a simplified one-compartment approach (t1/2 = ln 2Vss/CL), where Vss and CL are the steady-state volume of distribution and the total body clearance of drug, respectively. The analysis of the accuracy of this approach is provided. It turns out that most often a simplified one-compartment calculation underestimates t1/2 by no more than 25% for human, 26% for dog, 20% for monkey, 19% for rat, and 23% for mouse. Thus, the application of a one-compartment calculation of t1/2 is well justifiable, except for the rare cases of very high drug clearance (@@@@), where r is the equilibrium blood-plasma concentration ratio, and Q is the cardiac output. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:2082-2084, 2013
引用
收藏
页码:2082 / 2084
页数:3
相关论文
共 45 条
  • [21] Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension
    Li, Qing
    Barrett, Allison
    Vijayakrishnan, Balakumar
    Tiberghien, Arnaud
    Beard, Rhiannon
    Rickert, Keith W.
    Allen, Kevin L.
    Christie, R. Jim
    Marelli, Marcello
    Harper, Jay
    Howard, Philip
    Wu, Herren
    Dall'Acqua, William F.
    Tsui, Ping
    Gao, Changshou
    Borrok, M. Jack
    BIOCONJUGATE CHEMISTRY, 2019, 30 (04) : 1232 - 1243
  • [22] Nonlinear Elimination of Drugs in One-Compartment Pharmacokinetic Models: Nonstandard Finite Difference Approach for Various Routes of Administration
    Egbelowo, Oluwaseun
    MATHEMATICAL AND COMPUTATIONAL APPLICATIONS, 2018, 23 (02)
  • [23] An experience on the model-based evaluation of pharmacokinetic drug-drug interaction for a long half-life drug
    Hong, Yunjung
    Jeon, Sangil
    Choi, Suein
    Han, Sungpil
    Park, Maria
    Han, Seunghoon
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2021, 25 (06) : 545 - 553
  • [24] Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design
    Crawford, James J.
    Feng, Jianwen
    Brightbill, Hans D.
    Johnson, Adam R.
    Wright, Matthew
    Kolesnikov, Aleksandr
    Lee, Wendy
    Castanedo, Georgette M.
    Do, Steven
    Blaquiere, Nicole
    Staben, Steven T.
    Chiang, Po-Chang
    Fan, Peter W.
    Baumgardner, Matt
    Wong, Susan
    Godemann, Robert
    Grabbe, Alice
    Wiegel, Catharina
    Sujatha-Bhaskar, Swathi
    Hymowitz, Sarah G.
    Liau, Nicholas
    Hsu, Peter L.
    McEwan, Paul A.
    Ismaili, Moulay Hicham Alaoui
    Landry, Matthew L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 89
  • [25] Estimating the biological half-life for radionuclides in homoeothermic vertebrates: a simplified allometric approach
    Beresford, N. A.
    Vives i Batlle, J.
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2013, 52 (04) : 505 - 511
  • [26] A new simplified allometric approach for predicting the biological half-life of radionuclides in reptiles
    Beresford, N. A.
    Wood, M. D.
    JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, 2014, 138 : 116 - 121
  • [27] Cannabidiol Bioavailability Is Nonmonotonic with a Long Terminal Elimination Half-Life: A Pharmacokinetic Modeling-Based Analysis
    Kolli, Aditya R.
    Hoeng, Julia
    CANNABIS AND CANNABINOID RESEARCH, 2025, 10 (01) : 81 - 91
  • [28] Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
    Schneider, Eric L.
    Hearn, Brain R.
    Pfaff, Samuel J.
    Fontaine, Shaun D.
    Reid, Ralph
    Ashley, Gary W.
    Grabulovski, Stefanie
    Strassberger, Verena
    Vogt, Lorenz
    Jung, Thomas
    Santi, Daniel V.
    BIOCONJUGATE CHEMISTRY, 2016, 27 (10) : 2534 - 2539
  • [29] Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry
    Sinha, Vikash K.
    Vaarties, Karin
    De Buck, Stefan S.
    Fenu, Luca A.
    Nijsen, Marjoleen
    Gilissen, Ron A. H. J.
    Sanderson, Wendy
    Van Uytsel, Kelly
    Hoeben, Eva
    Van Peer, Achiel
    Mackie, Claire E.
    Smit, Johan W.
    CLINICAL PHARMACOKINETICS, 2011, 50 (05) : 307 - 318
  • [30] An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide
    Kim, Daejin
    Jeon, Hyungsu
    Ahn, Sukyung
    Choi, Won Il
    Kim, Sunghyun
    Jon, Sangyong
    JOURNAL OF CONTROLLED RELEASE, 2017, 256 : 114 - 120